Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetic nephropathy: leveraging mouse genetics.

Matthew D Breyer1, Zhonghua Qi, Elena Tchekneva

  • 1Division of Nephrology, Department of Medicine and Department of Molecular Physiology and Biophysics, Vanderbilt University, and Veterans Administration Medical Center, Nashville, Tennessee 3723, USA. matthew.breyer@vanderbilt.edu

Current Opinion in Nephrology and Hypertension
|April 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reversal of advanced diabetic kidney disease in mice treated with a monoclonal anti-VEGFR1 antibody.

Kidney international·2026
Same author

A novel mouse model for cardiovascular-kidney-metabolic syndrome: Bridging metabolic, renal and cardiac dysfunction.

Molecular metabolism·2026
Same author

Regulatory Mechanisms of Gut Homeostasis and Bone Metabolism Interplay in Osteoporosis.

Phenomics (Cham, Switzerland)·2025
Same author

Progress in Intestinal Homeostasis and Mechanisms of Pancreatic Cancer.

Phenomics (Cham, Switzerland)·2025
Same author

Collaborative optimization of the Mathews stability graph method and numerical simulation for the limit exposure area in stope.

Scientific reports·2025
Same author

The gut homeostasis-immune system axis: novel insights into rheumatoid arthritis pathogenesis and treatment.

Frontiers in immunology·2024
Same journal

Updates in management of cardiorenal syndrome.

Current opinion in nephrology and hypertension·2026
Same journal

Sex differences in renal acid-base regulation.

Current opinion in nephrology and hypertension·2026
Same journal

Primary prevention of chronic kidney disease in type 2 diabetes mellitus with sodium-glucose cotransporter 2 inhibitors.

Current opinion in nephrology and hypertension·2026
Same journal

Financial and policy challenges of delivering kidney replacement therapies in resource-limited settings.

Current opinion in nephrology and hypertension·2026
Same journal

The role of kir4.1/Kir5.1 in mediating the effect of angiotensin-II on Na-Cl-cotransporter.

Current opinion in nephrology and hypertension·2026
Same journal

Role of the calcium-sensing receptor in regulating calcium transport in the thick ascending limb.

Current opinion in nephrology and hypertension·2026
See all related articles

Recent mouse genetic models, like Akita and Ove26, offer new insights into diabetic nephropathy pathogenesis. These models complement human studies, aiding in the identification of genes contributing to this kidney disease.

Area of Science:

  • Genetics
  • Nephrology
  • Immunology

Background:

  • Mouse models are crucial for understanding human diseases.
  • Diabetic nephropathy is a significant complication of diabetes.

Purpose of the Study:

  • To review recent advances in understanding diabetic nephropathy pathogenesis using mouse models.
  • To highlight novel genetic mouse models and resources.

Main Methods:

  • Review of scientific literature on mouse models of diabetic nephropathy.
  • Characterization of genetic models including Akita, Ove26, and ICER-Igamma mice.
  • Discussion of mutagenesis resources and inbred genetic backgrounds.

Main Results:

  • Novel genetic models of murine diabetes have been characterized.

Related Experiment Videos

  • Mutagenesis resources and genetic background are important factors.
  • These models provide a platform for studying diabetic nephropathy.

    • Conclusions:

    • Mouse models offer valuable insights into diabetic nephropathy pathogenesis.
    • These models complement human studies and validate candidate genes.
    • Advances in mouse genetics enhance disease modeling capabilities.